Amgen, Inc. (AMGN)
429.88
-2.54
(-0.59%)
USD |
NASDAQ |
Aug 31, 16:00
433.00
+3.12
(+0.73%)
After-Hours: 20:00
Amgen Net Income (TTM) : 8.743B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.743B |
| March 31, 2026 | 7.80B |
| December 31, 2025 | 7.711B |
| September 30, 2025 | 7.005B |
| June 30, 2025 | 6.619B |
| March 31, 2025 | 5.933B |
| December 31, 2024 | 4.09B |
| September 30, 2024 | 4.23B |
| June 30, 2024 | 3.13B |
| March 31, 2024 | 3.763B |
| December 31, 2023 | 6.717B |
| September 30, 2023 | 7.566B |
| June 30, 2023 | 7.979B |
| March 31, 2023 | 7.917B |
| December 31, 2022 | 6.552B |
| September 30, 2022 | 6.835B |
| June 30, 2022 | 6.576B |
| March 31, 2022 | 5.723B |
| December 31, 2021 | 5.893B |
| September 30, 2021 | 5.609B |
| June 30, 2021 | 5.746B |
| March 31, 2021 | 7.085B |
| December 31, 2020 | 7.264B |
| September 30, 2020 | 7.352B |
| June 30, 2020 | 7.299B |
| Date | Value |
|---|---|
| March 31, 2020 | 7.675B |
| December 31, 2019 | 7.842B |
| September 30, 2019 | 8.067B |
| June 30, 2019 | 7.958B |
| March 31, 2019 | 8.075B |
| December 31, 2018 | 8.394B |
| September 30, 2018 | 2.202B |
| June 30, 2018 | 2.364B |
| March 31, 2018 | 2.219B |
| December 31, 2017 | 1.979B |
| September 30, 2017 | 8.178B |
| June 30, 2017 | 8.174B |
| March 31, 2017 | 7.893B |
| December 31, 2016 | 7.722B |
| September 30, 2016 | 7.587B |
| June 30, 2016 | 7.433B |
| March 31, 2016 | 7.216B |
| December 31, 2015 | 6.939B |
| September 30, 2015 | 6.433B |
| June 30, 2015 | 5.814B |
| March 31, 2015 | 5.708B |
| December 31, 2014 | 5.158B |
| September 30, 2014 | 4.885B |
| June 30, 2014 | 5.009B |
| March 31, 2014 | 4.72B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Gilead Sciences, Inc. | -3.24B |
| Regeneron Pharmaceuticals, Inc. | 4.329B |
| AbbVie, Inc. | 6.274B |
| Biogen, Inc. | 834.60M |
| Vertex Pharmaceuticals, Inc. | 4.405B |